NCT00353392

Brief Summary

The purpose of this study is to determine whether Q-Switched Nd:YAG Laser therapy are effective in reduction of Cutaneous macular amyloidosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Mar 2006

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2006

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

July 17, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 18, 2006

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2006

Completed
Last Updated

December 19, 2013

Status Verified

November 1, 2006

Enrollment Period

4 months

First QC Date

July 17, 2006

Last Update Submit

December 18, 2013

Conditions

Macular Amyloidosis

Outcome Measures

Primary Outcomes (1)

  • Visual and colorimetric assessment

Interventions

Laser TherapyDEVICE

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Macular amyloidosis confirmed cases

You may not qualify if:

  • Pregnancy and breast feeding
  • Over 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Skin Research Center, Shaheed Beheshti Medical University

Tehran, 19899, Iran

Location

MeSH Terms

Interventions

Laser Therapy

Intervention Hierarchy (Ancestors)

TherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Officials

  • Nima Ostovari, M.D.

    Shahid Beheshti University of Medical Sciences

    STUDY DIRECTOR

  • Parviz Toossi, MD

    Shaheed Beheshti Medica University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 17, 2006

First Posted

July 18, 2006

Study Start

March 1, 2006

Primary Completion

July 1, 2006

Study Completion

August 1, 2006

Last Updated

December 19, 2013

Record last verified: 2006-11

Locations

IR(1)